Romania’s pharmaceutical market distribution prices increased by 3.6% y/y to EUR 691.9mn in Q1/2013. The market edged up a mere 0.6% q/q in the quarter following difficulties stemming from regulatory and legislative constraints and not weak demand.
Prospects for the full-year pharmaceutical sales remain moderate. Market projections expect 1.4% y/y advance in local currency, while in EUR and USD terms the sales could even decline, depending on the evolution of the exchange rate.
Much more in the Intellinews report: Romania Pharmaceutical>>
Filed under: Europe, Healthcare, Industry, Pharmaceutical, Romania